Linagliptin Add-on to Insulin Background Therapy
Clinical trial NCT02897349 · COMPLETED
Trial details
- NCT number
- NCT02897349
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-30
- Primary completion
- 2019-01-11
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.